IBRO Neuroscience Reports, published by Elsevier, is a pivotal open-access journal dedicated to advancing the field of neuroscience. With its ISSN 2667-2421, the journal serves as a vital platform for researchers, professionals, and students alike, showcasing innovative research and interdisciplinary studies that span various aspects of neuroscience. Since its inception in 2021, and with a planned convergence through 2024, the journal has quickly established itself within the academic community, currently holding a Q3 category ranking in the field of Neuroscience (miscellaneous) and a Scopus rank of #77 among 113 in General Neuroscience, reflecting its ongoing commitment to quality and relevance. The accessibility of research articles ensures that critical findings are widely disseminated, fostering collaboration and dialogue within the neuroscientific community. Researchers and professionals are encouraged to contribute to this dynamic journal, reinforcing its role in shaping the future of neuroscience research.

PAIN is a renowned academic journal published by Lippincott Williams & Wilkins, specializing in the critical fields of *Anesthesiology* and *Pain Medicine*, as well as *Neurology* and *Pharmacology*. With an ISSN of 0304-3959 and an E-ISSN of 1872-6623, this influential journal has established itself as a premier platform for disseminating key findings and advancements in pain research since its inception in 1975. Recognized for its high impact factor, PAIN holds a commendable Q1 ranking across multiple categories, including a ranking of #3 out of 136 in *Anesthesiology and Pain Medicine,* which showcases its pivotal role in the scientific community. The journal’s comprehensive scope encompasses empirical studies, reviews, and clinical insights, making it indispensable for researchers, clinicians, and students dedicated to understanding and treating pain. Although currently not offering open access, PAIN ensures that readers have access to cutting-edge research backed by rigorous peer-review processes. Join a vibrant community of professionals committed to enhancing the management of pain and advancing neuroscience by engaging with the invaluable resources provided by PAIN.

Anaesthesia Critical Care & Pain Medicine is a leading academic journal published by Elsevier France - Editions Scientifiques Medicales Elsevier, known for its commitment to advancing knowledge in the fields of Anesthesiology, Critical Care, and Pain Medicine. With an impressive impact factor reflected by its Q1 rankings in pivotal categories such as Anesthesiology and Pain Medicine, and Critical Care and Intensive Care Medicine, this journal stands out for its rigorous peer-reviewed articles and innovative research contributions. Established in 2015, it provides a critical platform for international scholars and practitioners to disseminate their findings and engage with contemporary challenges in acute and pain management, ultimately improving patient care globally. With open access options available, the journal ensures that its significant research is accessible to a broader audience, encouraging collaboration and knowledge sharing within this vital field of medicine. For those at the forefront of medical practice, Anaesthesia Critical Care & Pain Medicine serves as an invaluable resource for ongoing education and professional development.

Journal of Endometriosis and Pelvic Pain Disorders, published by SAGE Publications Ltd, is a vital resource dedicated to advancing the understanding and management of endometriosis and associated pelvic pain disorders. With an ISSN of 2284-0265 and E-ISSN 2284-0273, this journal caters to a diverse audience of researchers, healthcare professionals, and students in the field of Obstetrics and Gynecology. It has a notable 2023 Scopus ranking of #139 out of 209 in its category, positioning it within the Q3 quartile based on its impact and contribution to the literature. The journal aims to publish cutting-edge research, reviews, and clinical guidelines that illuminate the complexities of endometriosis and enhance patient care. Available through various academic channels, it not only fosters scholarly discourse but also supports the academic community in addressing the challenges and advancements in the treatment of pelvic pain disorders. As the journal approaches its converged years from 2013 to 2024, it stands as a critical platform for disseminating impactful findings in a field that significantly affects women’s health globally.

Pain Research & Management, published by HINDAWI LTD, is a leading academic journal that serves as a vital resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and neurology. With an impressive impact factor and categorized in the second quartile (Q2) for both anesthesiology and neurology as of 2023, the journal features high-quality, peer-reviewed research articles that address the complexities of pain management. Established in 1996 and recognized as Open Access, this journal allows unrestricted access to groundbreaking studies, thereby facilitating knowledge dissemination and collaboration within the global scientific community. With a strong ranking—34/136 in anesthesiology and 72/192 in neurology—Pain Research & Management retains a well-deserved reputation for publishing innovative and authoritative content that significantly contributes to the advancement of pain research and clinical practice. Researchers and healthcare professionals alike will find this journal indispensable for staying abreast of the latest discoveries and best practices in pain management.

The European Journal of Pain, published by Wiley, is a premier peer-reviewed journal specializing in the fields of Anesthesiology and Pain Medicine. With an impressive impact factor and a prestigious ranking in the Q1 category for both Anesthesiology and Pain Medicine, as well as Miscellaneous Medicine, this journal stands out in the academic landscape, significantly contributing to the understanding and treatment of pain across various patient populations. Operating since 1997 and continuing through 2024, the journal provides a platform for groundbreaking research, reviews, and clinical studies, making it an invaluable resource for researchers, practitioners, and students alike. While it operates under a subscription model, the rigorous peer-review process ensures that readers access high-quality, evidence-based content that is essential for the advancement of pain management and anesthetic practices globally.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.

Neuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.

Pain Physician is a premier journal that plays a critical role in the field of anesthesiology and pain medicine, published by the American Society of Interventional Pain Physicians. With an impressive impact factor and ranked in the Q1 category of Scopus for its significant contributions to the literature, the journal has established itself as a leading source of innovative research and clinical insights since its inception in 1999. Covering a wide array of topics related to pain management, the journal aims to disseminate high-quality studies that inform best practices and enhance patient care. As a well-respected publication, Pain Physician offers essential access to the latest developments and methodologies in pain therapy to researchers, clinicians, and students alike, fostering a deeper understanding of this critical area of medicine. With its commitment to advancing research and practice, Pain Physician is an invaluable resource for those dedicated to improving the quality of life for individuals suffering from chronic pain.

Frontiers in Pain Research is a leading open-access journal published by FRONTIERS MEDIA SA in Switzerland, devoted exclusively to advancing our understanding of pain, its mechanisms, and management. With an E-ISSN of 2673-561X and a strong dedication to academic rigor, the journal has quickly gained recognition in the field, boasting significant standings in various categories: Q2 in Anesthesiology and Pain Medicine and Q1 in Health Professions (miscellaneous) as of 2023. This interdisciplinary journal aims to facilitate the dissemination of novel research findings and therapeutic insights, contributing to enhanced patient care and improved outcomes. It holds credible ranks such as 20th percentile in Health Professions and 66th in Anesthesiology, solidifying its role as a vital resource for researchers, healthcare professionals, and students. The journal is committed to providing unrestricted access to its published works to spark global collaboration and dialogue in the crucial area of pain research.